Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.

Area of Science:

• Nephrology
• Endocrinology
• Surgical Research

Background:

• Secondary hyperparathyroidism (SHPT) is often expected to resolve after successful kidney transplantation (KT).
• However, a notable percentage of KT recipients develop persistent SHPT, necessitating further intervention.
• Parathyroidectomy (PTX) becomes a required treatment for some patients post-KT.

Purpose of the Study:

• To analyze 42 patients who underwent PTX for persistent SHPT after KT.
• To identify pre-transplant risk factors associated with the need for PTX in kidney allograft recipients.

Main Methods:

• Retrospective case-controlled study involving 1332 kidney allograft recipients transplanted between 1989 and 2000.
• Patient data, including demographic, clinical, and biochemical variables, were reviewed.
• A control group, matched for transplantation time, was used for comparison.

Main Results:

• Persistent SHPT requiring PTX occurred in 4.1% of KT patients (55/1332).
• Eligible for analysis were 42 patients with a mean age of 52 years; PTX occurred at a mean of 416 days post-KT.
• Risk factors identified included longer pre-transplant dialysis duration (36.3 vs. 23.0 months) and higher pre-transplant levels of intact parathyroid hormone (iPTH), serum calcium, and alkaline phosphatases.

Conclusions:

• Persistent hyperparathyroidism requiring PTX is a significant clinical issue following successful KT.
• Patients with extended pre-transplant dialysis and elevated pre-transplant iPTH, calcium, and alkaline phosphatase levels are at increased risk.
• Subtotal parathyroidectomy was effective with low morbidity and recurrence rates.